Remove Packaging Remove Production Remove Vaccine
article thumbnail

A Visual Guide to Gene Delivery

Codon

Some diseases are caused by mutations in large genes that exceed the packaging limits of existing vectors like adeno-associated virus (AAV). Its exact packaging size can vary by serotype, and there are now more than 20 antigenically distinct types of AAV. Still, AAV’s most obvious limitation remains its packaging capacity (~4.7

article thumbnail

Edwin Cohn and the Harvard Blood Factory

Codon

military approached Cohn about developing medical products from blood proteins to treat shock and blood loss in soldiers. During the Normandy beach landings, many wounded soldiers were treated with Cohn’s albumin products. Production numbers of human plasma fractionation products, 1942-1946. Cohn answered the call.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Levers for Biological Progress

Codon

Such models will, in turn, make it much easier to invent the sorts of platform tools that Amodei asserts “drive >50% of progress in biology,” such as CRISPR and mRNA vaccines, because the creation of these tools ultimately derive from a deeper understanding of how cells work.

DNA
article thumbnail

The Uncertain Origins of Aspirin

Codon

A report was sent to Bayer detailing the results of these tests, upon which Dreser commented: “ the product has no value. NSAID Expansion: 1949 to present While it is seemingly impossible to find figures for aspirin consumption or production over time, it is clear that it took off after Bayer began marketing the drug in 1899.

article thumbnail

AstraZeneca’s COVID-19 Vaccine Boasts Strong Results with Up to 90% Efficacy

The Pharma Data

As the Pfizer and BioNTech COVID-19 vaccine goes to regulators and the Moderna vaccine approaches the end of its Phase III trials, AstraZeneca and the University of Oxford announced high-level results from an interim analysis of their COVID-19 vaccine, AZD1222. The combined analysis showed average efficacy of 70%.

article thumbnail

China’s ‘insect’ vaccine for COVID-19 approved for human testing

The Pharma Data

China is set to move ahead with human testing of a potential coronavirus vaccine that has been created using insect cells. The National Medical Products Administration has granted approval to the West China Hospital of Sichuan University in Chengdu to begin a clinical trial. These were primarily border officials and health workers.

article thumbnail

Keeping tabs on Covid-19: FDA approves Veklury as first treatment for Covid-19 and Takeda and Moderna bring 50 million vaccines to Japan

The Pharma Data

To increase demand for products during the novel coronavirus pandemic, the US Food and Drug Administration (FDA) has already approved at-home testing and investigated the effectiveness of malaria pills and other antiviral drugs to treat Covid-19 9. Takeda and Moderna join forces to expand Covid-19 vaccine supply in Japan.